Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 vistas
administrator
07/10/23
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Mostrar más
Comentarios de Facebook
No se encontraron comentarios